Activity ID
13249Expires
March 19, 2027Format Type
EnduringCME Credit
0.5Fee
30CME Provider: American Medical Association
Description of CME Course
Opioid use disorder, or OUD, is a treatable medical condition. However, disparities in access to medications for opioid use disorder (MOUD) continue to be a challenge. We’ll examine disparities in access for people with disabilities, racial and ethnic variations to access, and geographic maldistribution of relevant providers and services. Addressing access to MOUD is a critical piece in combating the opioid overdose epidemic.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Discuss how race, ethnicity, geography, and disabling conditions impact access to medications for opioid use disorder
2. Explain how addressing stigma and accessibility can improve equity in access to medications for opioid use disorder
3. Describe strategies to improve disparities in who can easily access medications for opioid use disorder
Keywords
Opioids, Substance Use and Addiction Medicine, Health Disparities
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/ama.2024.0000058
